Camorena Medical Center is categorized under Medical Centers in Pico Rivera, CA and active since 2009.
Camorena Medical Center was established in 2009, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Centers business, which does work in the B2C market, and is classified as a Medical Centers, under code number 6219992 by the NAICS.
If you are seeking more information, feel free to contact Anthony Cappelli, Principal at the company’s single location by writing to 6650 Rosemead Boulevard, Pico Rivera, California CA 90660 or by phoning (562) 949-6515. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Camorena Medical Center |
| Contact Person: | Anthony Cappelli, Principal |
| Address: | 6650 Rosemead Boulevard, Pico Rivera, California 90660 |
| Phone Number: | (562) 949-6515 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Centers |
| SIC Code: | 8011 |
| NAICS Code: | 6219992 |
| Share This Business: |
Camorena Medical Center was started in 2009 to provide professional Medical Centers under the SIC code 8011 and NAICS code 6219992. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Anthony Cappelli, Principal for inquiries that concern Camorena Medical Center by calling the company number (562) 949-6515, as your correspondence is most welcome. Additionally, the physical location of the single location of Camorena Medical Center can be found at the coordinates 33.98484,-118.09563 as well as the street address 6650 Rosemead Boulevard in Pico Rivera, California 90660.
For its online presence, you may visit Camorena Medical Center’s website at and engage with its social media outlets through on Twitter and on Facebook.